US 10485800
Mixed lineage kinase inhibitors for HIV/AIDS therapies
granted A61KA61K31/427A61K31/437
Quick answer
US patent 10485800 (Mixed lineage kinase inhibitors for HIV/AIDS therapies) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
- Grant date
- Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/427, A61K31/437, A61K31/4418, A61K31/444